Hepatology - European Medical Journal

Continue

Hepatology

Filter
EMJ
27 Jun 2016

Protein Successfully Predicts Recurrence of Liver Cancer

INVESTIGATIONS of p62 have highlighted the protein as a key factor in cancer recurrence and has been associated with reduced rates of survival in liver…
EMJ
27 Jun 2016

Restricted Calorie Intake Reduces Fat Content of Liver

GROWING rates of obesity have raised concerns regarding the resulting metabolic diseases caused by overeating, such as Type 2 diabetes and liver disease…
EMJ
15 Apr 2016

UK Study Shows Rifaximin-α Significantly Reduces Hospital Resource Use for Patients with Hepatic Encephalopathy

LONDON, UK, Thursday 14 April, 07:00 BST: Norgine B.V. presented new positive UK real world practice data from the IMPRESS retrospective observational…
EMJ
29 Mar 2016

Hepatitis C Provides Potent Antiviral Molecules

RESISTANT viruses may soon face a potent new antiviral body in the form of the amphipathic α-helical (AH) peptide, a molecule found within the hepatitis…
EMJ
29 Mar 2016

Team Discover Achilles’ Heel of Liver Cancer

DEADLY liver cancer may have met its match, with the discovery of stem cell markers in the biological makeup of hepatocellular carcinoma.
EMJ
14 Mar 2016

Sneaking through Barrier Gaps: Gut Microbiota Imbalance Harms the Liver

March 14, 2016: The potential consequences of gut microbial dysbiosis are not restricted to bowel conditions only. Prominent among the other organs…
EMJ
19 Feb 2016

Introducing the European Medical Journal 1.1

United Kingdom, February 19, 2016: The first edition of the European Medical Journal is available now, this is the first of four issues new for 2016.
EMJ
8 Dec 2015

European Medicines Agency Validates Gilead’s Marketing Application for Investigational Fixed-Dose Combination of Sofosbuvir/Velpatasvir for the Treatment of Hepatitis C

Foster City, Calif., December 4, 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its Marketing Authorization Application (MAA) for…